➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Harvard Business School
Baxter
Moodys
Dow

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Psilocybin


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Psilocybin?

Psilocybin is an investigational drug.

There have been 60 clinical trials for Psilocybin. The most recent clinical trial was a Phase 1 trial, which was initiated on January 15th 2019.

The most common disease conditions in clinical trials are Depressive Disorder, Depression, and Disease. The leading clinical trial sponsors are Heffter Research Institute, Johns Hopkins University, and COMPASS Pathways.

There are seven hundred and twenty-seven US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Psilocybin
TitleSponsorPhase
Psilocybin for Psychological and Existential Distress in Palliative CareBruyere Research InstitutePhase 1/Phase 2
Psilocybin for Psychological and Existential Distress in Palliative CareCentre de recherche du Centre hospitalier universitaire de SherbrookePhase 1/Phase 2
Psilocybin for Psychological and Existential Distress in Palliative CareCHU de Quebec-Universite LavalPhase 1/Phase 2

See all Psilocybin clinical trials

Clinical Trial Summary for Psilocybin

Top disease conditions for Psilocybin
Top clinical trial sponsors for Psilocybin

See all Psilocybin clinical trials

US Patents for Psilocybin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Psilocybin   Get Started Free Devices and methods for continuous analyte monitoring DexCom, Inc. (San Diego, CA)   Get Started Free
Psilocybin   Get Started Free Devices and methods for continuous analyte monitoring DexCom, Inc. (San Diego, CA)   Get Started Free
Psilocybin   Get Started Free Indicator and analytics for sensor insertion in a continuous analyte monitoring system and related methods DexCom, Inc. (San Diego, CA)   Get Started Free
Psilocybin   Get Started Free Advanced analyte sensor calibration and error detection DexCom, Inc. (San Diego, CA)   Get Started Free
Psilocybin   Get Started Free Drug device configured for wireless communication Pop Test Abuse Deterrent Technology, LLC (Cliffside Park, NJ)   Get Started Free
Psilocybin   Get Started Free Personal substance detection field test kit Lindon Group, Inc. (East Providence, RI)   Get Started Free
Psilocybin   Get Started Free Wearable apparatus for detecting a target substance in a liquid Undercover Colors, Inc. (Raleigh, NC)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Psilocybin

Drugname Country Document Number Estimated Expiration Related US Patent
Psilocybin European Patent Office EP3069279 2033-11-14   Get Started Free
Psilocybin World Intellectual Property Organization (WIPO) WO2015073459 2033-11-14   Get Started Free
Psilocybin European Patent Office EP3069279 2033-11-14   Get Started Free
Psilocybin World Intellectual Property Organization (WIPO) WO2015073459 2033-11-14   Get Started Free
Psilocybin European Patent Office EP3068302 2033-11-14   Get Started Free
Psilocybin World Intellectual Property Organization (WIPO) WO2015073588 2033-11-14   Get Started Free
Psilocybin European Patent Office EP2697650 2031-04-15   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Boehringer Ingelheim
Merck
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.